Tangshen Formula attenuates diabetic kidney injury by imparting anti-pyroptotic effects via the TXNIP-NLRP3-GSDMD axis
The SURPASS trials are designed to evaluate once-weekly tirzepatide doses of 5 mg, 10 mg, and 15 mg with a dose escalation algorithm: starting dose at 2.5 mg weekly for the first 4 weeks, then dose increment of 2.5 mg every 4 weeks until the maintenance dose of 5 mg, 10 mg, or 15 mg is achieved
It works to neutralize free radicals, or unstable molecules generated by UV exposure, pollution, and other environmental stressors, before they can cause oxidative damage to your skin cells
The fed-batch culture was performed in a 5-L bioreactor (NC-Bio, Shanghai, China) with the initial working volume of 2.5 L
Mol Metab 2015, 4: 718731
Ozempic is the brand name for semaglutide a GLP1 receptor agonist originally designed for type 2 diabetes